Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric-Inspired Regimen for Adults With Newly Diagnosed Ph Negative ALL
NCT01920737Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2013
- Primary completion
- Aug 2027
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of daunorubicin, vincristine, prednisone, pegaspargase, methotrexate in acute lymphoblastic leukemia (ALL), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2013; status: active, not recruiting.
02
Drugs
daunorubicinvincristineprednisonepegaspargasemethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01920737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920737.